当前位置:首页 - 行情中心 - 拓新药业(301089) - 财务分析 - 现金流量表

拓新药业

(301089)

  

流通市值:27.57亿  总市值:38.34亿
流通股本:9097.63万   总股本:1.27亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金149,408,894.7668,877,403.51374,096,487.58321,978,358.66
  收到的税费返还4,085,687.952,710,713.6830,715,583.1330,185,454.79
  收到其他与经营活动有关的现金7,552,218.362,475,514.6113,257,859.5611,820,467.14
  经营活动现金流入小计161,046,801.0774,063,631.8418,069,930.27363,984,280.59
  购买商品、接受劳务支付的现金73,059,052.8743,443,850.6106,663,533.4491,666,291.24
  支付给职工以及为职工支付的现金72,686,028.3238,025,608.78143,870,276.56108,824,313.22
  支付的各项税费14,427,513.1212,056,344.7122,736,643.4818,306,034.43
  支付其他与经营活动有关的现金23,888,841.868,548,364.4142,130,775.8736,058,762.4
  经营活动现金流出小计184,061,436.17102,074,168.5315,401,229.35254,855,401.29
  经营活动产生的现金流量净额-23,014,635.1-28,010,536.7102,668,700.92109,128,879.3
二、投资活动产生的现金流量:
  收回投资收到的现金470,000,000340,000,000610,000,000460,000,000
  取得投资收益收到的现金2,578,804.381,887,265.553,434,029.352,963,289.62
  处置固定资产、无形资产和其他长期资产收回的现金净额--602,194.76183,508.47
  投资活动现金流入小计472,578,804.38341,887,265.55614,036,224.11463,146,798.09
  购建固定资产、无形资产和其他长期资产支付的现金18,597,614.9810,644,850.8383,912,345.5157,234,306.39
  投资支付的现金435,000,000220,000,000670,000,000420,000,000
  投资活动现金流出小计453,597,614.98230,644,850.83753,912,345.51477,234,306.39
  投资活动产生的现金流量净额18,981,189.4111,242,414.72-139,876,121.4-14,087,508.3
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金---91,513.15
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---91,513.15
  分配股利、利润或偿付利息支付的现金--31,636,12531,636,125
  支付其他与筹资活动有关的现金--936,798.21-
  筹资活动现金流出平衡项目--00
  筹资活动现金流出小计--32,572,923.2131,636,125
  筹资活动产生的现金流量净额平衡项目--00
  筹资活动产生的现金流量净额---32,572,923.21-31,544,611.85
四、汇率变动对现金及现金等价物的影响131,607.96183,629.72828,794.4461,882.52
五、现金及现金等价物净增加额-3,901,837.7483,415,507.74-68,951,549.2563,558,641.67
  加:期初现金及现金等价物余额61,781,733.2561,781,733.25130,733,282.5130,733,282.5
  期末现金及现金等价物余额57,879,895.51145,197,240.9961,781,733.25194,291,924.17
补充资料:
  净利润-18,280,549.55--19,884,868.92-
  资产减值准备7,316,298.7-10,678,437.92-
  固定资产和投资性房地产折旧23,902,641.19-43,790,598.62-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧23,902,641.19-43,790,598.62-
  无形资产摊销1,395,802.04-3,600,310.39-
  长期待摊费用摊销434,141.28-833,883.95-
  处置固定资产、无形资产和其他长期资产的损失--5,674.6-
  固定资产报废损失277,289.27-1,415,182.76-
  公允价值变动损失-755,247.22--875,756.43-
  财务费用-54,910.49--778,717.16-
  投资损失-1,703,047.95--677,321.82-
  递延所得税-3,455,836.94--7,957,780.85-
  其中:递延所得税资产减少-2,916,489.5--5,874,886.52-
    递延所得税负债增加-539,347.44--2,082,894.33-
  存货的减少-13,811,386.09-14,549,733.39-
  经营性应收项目的减少-31,143,139.3-72,827,307.25-
  经营性应付项目的增加13,367,576--19,275,087.42-
  现金的期末余额57,879,895.51-61,781,733.25-
  减:现金的期初余额61,781,733.25-130,733,282.5-
  现金及现金等价物的净增加额-3,901,837.74--68,951,549.25-
公告日期2025-08-272025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑